Company & Sponsor Intelligence
Institute of Mental Health, Singapore
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
autismdepression
Indexed studies
NCT03115671Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)
autism · SingaporeNA
autism · SingaporeNA
NCT03941106Accelerated Transcranial Magnetic Stimulation (aTBS) to Treat Depression
depression · SingaporeNA
depression · SingaporeNA
NCT05452746Acupuncture Augmentation for Inpatients With Major Depression Disorder
depression · SingaporeNA
depression · SingaporeNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →